Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ: SLNO )

44.52 -1.70 (-3.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Why Soleno Therapeutics Stock Blasted 9% Higher Today
The company's Prader-Willi treatment inched closer to FDA approval. 
Via The Motley Fool
Exposures Product Safety
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
SLNO Stock Earnings: Soleno Therapeutics Beats EPS for Q2 2024
SLNO stock results show that Soleno Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Soleno Therapeutics Stock Is Skyrocketing Today
The clinical-stage biotech company received great news from the FDA. 
Via The Motley Fool
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/22
Via Investor Brand Network
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc.... 
Via Benzinga
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/20
Via Investor Brand Network
Soleno Therapeutics Inc. (NASDAQ: SLNO) Climbs to New 52-Week High
Via Investor Brand Network
4 Analysts Have This to Say About Soleno Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Forget The Magnificent 7: Did Anyone Back These 1,000% Gainers In 2023?
Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%. 
Via Benzinga
Topics ETFs
These Two Companies Surpass Nvidia, Apple And Microsoft with Astounding 1000% Returns In 2023
The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Apple, and Microsoft. 
Via Benzinga
Why Soleno Therapeutics Stock Ticked Higher on Thursday
The latest pundit take on the stock provided a good reason for bulls to snap it up. 
Via The Motley Fool
Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023
These three stocks to take profits on rallied more than 200% this year. Those gains are exceedingly unlikely to repeat in 2024. 
Via InvestorPlace
3 Stock Winners That Are Up 500% or More in 2023
If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January 
Via InvestorPlace
7 Stock Winners That Are Up 1,000% or More in 2023
Could any or all of these seven stocks up 1000% this year go on another hot run during 2024? Let's find out. 
Via InvestorPlace
5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains
These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent. 
Via InvestorPlace
Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.
When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky. 
Via InvestorPlace
3 Biotech Stocks With Big-Time Breakthrough Potential
The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave. 
Via InvestorPlace
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
Some big 2023 winners are shorted heavily, including two AI plays. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 5 Health Care Stocks That May Plunge In October
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
Soleno Therapeutics is working on a treatment for Prader Willi syndrome, a genetic disease that causes obesity. 
Via Investor's Business Daily
Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.